查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1472297

全球睪酮替代療法市場：按產品類型、活性成分和最終用戶 - 機會分析和產業預測，2023-2032

Testosterone Replacement Therapy Market By Product Type, By Active ingredients, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 270 Pages | 商品交期: 2-3個工作天內

價格

全球睪固酮替代療法市場規模預計到2022年將達到19億美元，2023年至2032年複合年成長率為4.2%，2032年將達到29億美元。

睾酮替代療法市場-IMG1

睾酮替代療法是一種旨在解決睾酮水平低下問題的醫療干預措施。睪固酮是一種重要的激素，負責男性生殖組織的發育和維持男性特徵，如肌肉質量、骨骼密度和臉部毛髮。隨著男性年齡的成長，他們的睪固酮水平往往會自然下降，導致各種症狀，包括疲勞、性慾下降和肌肉質量損失。睪固酮替代療法包括透過注射、貼片、凝膠或植入皮下的顆粒來施用外源性睪固酮。其目的是將睪酮水平恢復到正常範圍並減輕相關症狀。

睪固酮替代療法市場的成長歸因於性腺功能減退症盛行率的上升以及肥胖、糖尿病和METABOLIC INC.症候群等慢性疾病發病率的上升，這些疾病與低睪固酮水平的風險增加有關。近年來，性腺功能減退症的盛行率顯著上升，並已成為睾酮替代療法市場成長的關鍵驅動力。性腺功能減退症的特徵是睪丸中睪酮生成不足，影響很大一部分男性群體，尤其是隨著老齡化。例如，國家醫學圖書館 2021 年的一份報告估計，中老年男性性腺功能減退症的盛行率在 2.1% 至 38.7% 之間。睾酮替代療法已成為醫療保健專業人員解決與性腺功能減退症相關的荷爾蒙失衡的主要選擇。因此，性腺功能減退症盛行率的增加預計將推動市場成長。

此外，導致睪固酮水平低下的肥胖和糖尿病等慢性疾病發病率的增加預計將推動市場成長。糖尿病、肥胖和心血管疾病等慢性疾病在世界各地變得越來越普遍，導致荷爾蒙失衡、尤其是睪固酮水平低下的人數急劇增加。科學研究已經確定了慢性疾病與睪固酮生成減少之間的直接相關性，從而產生了大量尋求有效治療性介入來治療睪固酮水平低下的患者群體。美國國家醫學圖書館 2023 年的報告指出，男性肥胖與荷爾蒙失調有關，荷爾蒙失調會導致荷爾蒙和生殖性腺功能受損。據報導，高達 45% 的中度至重度肥胖患者患有與肥胖相關的性腺功能減退症。因此，肥胖和糖尿病等慢性病發病率的增加預計將推動睾酮替代療法市場的成長。然而，與化學換膚和光療相關的副作用正在限制市場的成長。美國心臟學會基金會 2023 年的報告顯示，在接受睪固酮替代療法的受試者中，肺動脈栓塞、非致命性心律不整、心房顫動和急性損傷的發生率較高。

睪固酮替代療法市場按產品類型、活性成分、最終用戶和地區細分。依產品類型分類，市場分為注射劑、外用藥物等。其他產品類型包括口服、植入和鼻腔製劑。依活性成分分類，市場分為環丙酸睪酮、睪酮、庚酸睪酮、十一酸睪酮等。依最終使用者分為醫院和診所。按地區分類：北美（美國、加拿大、墨西哥）、歐洲（德國、法國、英國、義大利、西班牙、歐洲其他地區）、亞太地區（日本、中國、澳洲、印度、韓國、亞太地區其他地區） ）、歐洲（巴西、哥倫比亞、阿根廷和亞太其他地區）和中東/非洲（海灣合作理事會、南美洲、北非和中東/非洲其他地區）。

相關人員的主要利益

  • 本報告定量分析了 2022 年至 2032 年睾酮替代療法市場分析的細分市場、當前趨勢、估計/趨勢和動態，以確定主要的睾酮替代療法市場機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析強調買家和供應商幫助相關人員做出利潤驅動的商業決策並加強供應商-買家網路的潛力。
  • 對睾酮替代療法市場細分的詳細分析有助於識別市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場參與者定位有助於基準化分析，並提供對市場參與者當前地位的清晰了解。
  • 該報告包括對區域和全球睾酮替代療法市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

可以使用此報告進行客製化

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 主要參與者的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章睾酮替代療法市場：依產品類型

  • 概述
  • 注射
  • 外用製劑
  • 其他

第5章睪酮替代療法市場：依活性成分分類

  • 概述
  • 環丙酸睪酮
  • 睪固酮
  • 庚酸睪酮
  • 十一酸睪酮
  • 其他

第6章 睪固酮替代療法市場：依最終用戶分類

  • 概述
  • 醫院
  • 診所

第7章 睪酮替代治療市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 哥倫比亞
    • 阿根廷
    • 其他拉丁美洲
  • 中東/非洲
    • GCC
    • 南非
    • 北非
    • 其他中東/非洲

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • AbbVie Inc.
  • Besins Healthcare SA
  • Acerus Pharmaceuticals Corporation
  • Amneal Pharmaceuticals Inc.
  • Acrux Ltd.
  • Endo International plc.
  • Biote Medical LLC
  • Insud Pharma SL
  • Marius Pharmaceuticals
  • Pfizer Inc.
Product Code: A08394

The global testosterone replacement therapy market was valued at $1.9 billion in 2022, and is projected to reach $2.9 billion by 2032, growing at a CAGR of 4.2% from 2023 to 2032.

Testosterone Replacement Therapy Market - IMG1

Testosterone replacement therapy is a medical intervention designed to address low levels of testosterone. Testosterone is a crucial hormone responsible for the development of male reproductive tissues and the maintenance of male characteristics, such as muscle mass, bone density, and facial hair. As men age, testosterone levels tend to decline naturally, leading to various symptoms such as fatigue, reduced libido, and loss of muscle mass. Testosterone replacement therapy involves the administration of exogenous testosterone through methods such as injections, patches, gels, or pellets implanted under the skin. The goal is to restore testosterone levels to a normal range and alleviate associated symptoms.

The testosterone replacement therapy market growth is attributed rise in prevalence of hypogonadism and the rising incidence of chronic diseases such as obesity, diabetes, and metabolic syndrome, which are associated with an increased risk of low testosterone levels. The prevalence of hypogonadism has witnessed a notable rise in recent years, emerging as a significant driver for the growth of testosterone replacement therapy market. Hypogonadism, characterized by the insufficient production of testosterone in the testes, affects a considerable portion of the male population, particularly as they age. For instance, according to 2021 report by National Library of Medicine, it was estimated that the prevalence of hypogonadism in middle-aged and older men varies between 2.1% and 38.7%. Testosterone replacement therapy has become a primary choice for healthcare professionals in addressing the hormonal imbalances associated with hypogonadism. Thus, a rise in prevalence of hypogonadism is expected to drive the growth of the market.

In addition, rise in incidence of chronic diseases such as obesity and diabetes which causes low testosterone is expected to drive the market growth. Chronic diseases, including diabetes, obesity, and cardiovascular ailments, have become increasingly prevalent worldwide, contributing to a surge in individuals experiencing hormonal imbalances, particularly low testosterone levels. Scientific studies have established a direct correlation between chronic illnesses and reduced testosterone production, creating a substantial patient pool seeking effective therapeutic interventions to treat low testosterone levels. According to 2023 report by National Library of Medicine, it was reported that male obesity is linked to hormonal disturbances leading to impaired gonadal functions, both hormonal and reproductive. Male obesity-related hypogonadism has been reported in up to 45% of patients with moderate to severe obesity. Thus, rise in incidence of chronic diseases, such as obesity and diabetes, is expected to drive the growth of the testosterone replacement therapy market. However, side effects associated with the chemical peels and photo therapy restrain the growth of the market. According to the 2023 report by American College of Cardiology Foundation, it was reported that the incidence of pulmonary embolism, nonfatal arrhythmia, atrial fibrillation, and acute injury was higher in subjects who received testosterone replacement therapy.

The testosterone replacement therapy market is segmented on the basis of product type, active ingredient, end user, and region. By product type, the market is classified into injectables, topical, and others. Other product types include oral, implant, and intranasal formulations. By active ingredient, the market is divided into testosterone cypionate, testosterone, testosterone enanthate, testosterone undecanoate, others. By end user, it is segregated into hospitals, and clinics. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA).

Major key players that operate in the testosterone replacement therapy market are AbbVie Inc, Besins Healthcare SA, Acerus Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Acrux Ltd., Endo International Plc, Biote Medical, LLC, Pfizer Inc., Insud Pharma S.L, and Marius Pharmaceuticals. Key players have adopted acquisition as a key developmental strategy to improve the product portfolio of the testosterone replacement therapy market

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the testosterone replacement therapy market analysis from 2022 to 2032 to identify the prevailing testosterone replacement therapy market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the testosterone replacement therapy market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global testosterone replacement therapy market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product Type

  • Injectables
  • Topical
  • Others

By Active ingredients

  • Testosterone Undecanoate
  • Others
  • Testosterone Cypionate
  • Testosterone
  • Testosterone Enanthate

By End User

  • Hospital
  • Clinics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Colombia
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Gcc
    • South Africa
    • North Africa
    • Rest Of Mea

Key Market Players:

    • AbbVie Inc.
    • Besins Healthcare SA
    • Acerus Pharmaceuticals Corporation
    • Amneal Pharmaceuticals Inc.
    • Acrux Ltd.
    • Endo International plc.
    • Biote Medical LLC
    • Insud Pharma S.L
    • Marius Pharmaceuticals
    • Pfizer Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Injectables
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Topical
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Others
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Testosterone Cypionate
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Testosterone
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Testosterone Enanthate
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Testosterone Undecanoate
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Others
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospital
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Clinics
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: TESTOSTERONE REPLACEMENT THERAPY MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product Type
    • 7.2.3. Market size and forecast, by Active ingredients
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product Type
      • 7.2.5.1.2. Market size and forecast, by Active ingredients
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product Type
      • 7.2.5.2.2. Market size and forecast, by Active ingredients
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product Type
      • 7.2.5.3.2. Market size and forecast, by Active ingredients
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product Type
    • 7.3.3. Market size and forecast, by Active ingredients
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product Type
      • 7.3.5.1.2. Market size and forecast, by Active ingredients
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product Type
      • 7.3.5.2.2. Market size and forecast, by Active ingredients
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product Type
      • 7.3.5.3.2. Market size and forecast, by Active ingredients
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product Type
      • 7.3.5.4.2. Market size and forecast, by Active ingredients
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product Type
      • 7.3.5.5.2. Market size and forecast, by Active ingredients
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product Type
      • 7.3.5.6.2. Market size and forecast, by Active ingredients
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product Type
    • 7.4.3. Market size and forecast, by Active ingredients
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product Type
      • 7.4.5.1.2. Market size and forecast, by Active ingredients
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product Type
      • 7.4.5.2.2. Market size and forecast, by Active ingredients
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product Type
      • 7.4.5.3.2. Market size and forecast, by Active ingredients
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Product Type
      • 7.4.5.4.2. Market size and forecast, by Active ingredients
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product Type
      • 7.4.5.5.2. Market size and forecast, by Active ingredients
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product Type
      • 7.4.5.6.2. Market size and forecast, by Active ingredients
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. Latin America
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product Type
    • 7.5.3. Market size and forecast, by Active ingredients
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product Type
      • 7.5.5.1.2. Market size and forecast, by Active ingredients
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Colombia
      • 7.5.5.2.1. Market size and forecast, by Product Type
      • 7.5.5.2.2. Market size and forecast, by Active ingredients
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. Argentina
      • 7.5.5.3.1. Market size and forecast, by Product Type
      • 7.5.5.3.2. Market size and forecast, by Active ingredients
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of Latin America
      • 7.5.5.4.1. Market size and forecast, by Product Type
      • 7.5.5.4.2. Market size and forecast, by Active ingredients
      • 7.5.5.4.3. Market size and forecast, by End User
  • 7.6. Middle East and Africa
    • 7.6.1. Key market trends, growth factors and opportunities
    • 7.6.2. Market size and forecast, by Product Type
    • 7.6.3. Market size and forecast, by Active ingredients
    • 7.6.4. Market size and forecast, by End User
    • 7.6.5. Market size and forecast, by country
      • 7.6.5.1. Gcc
      • 7.6.5.1.1. Market size and forecast, by Product Type
      • 7.6.5.1.2. Market size and forecast, by Active ingredients
      • 7.6.5.1.3. Market size and forecast, by End User
      • 7.6.5.2. South Africa
      • 7.6.5.2.1. Market size and forecast, by Product Type
      • 7.6.5.2.2. Market size and forecast, by Active ingredients
      • 7.6.5.2.3. Market size and forecast, by End User
      • 7.6.5.3. North Africa
      • 7.6.5.3.1. Market size and forecast, by Product Type
      • 7.6.5.3.2. Market size and forecast, by Active ingredients
      • 7.6.5.3.3. Market size and forecast, by End User
      • 7.6.5.4. Rest Of Mea
      • 7.6.5.4.1. Market size and forecast, by Product Type
      • 7.6.5.4.2. Market size and forecast, by Active ingredients
      • 7.6.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. AbbVie Inc.
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Besins Healthcare SA
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Acerus Pharmaceuticals Corporation
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Amneal Pharmaceuticals Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. Acrux Ltd.
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Endo International plc.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Biote Medical LLC
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.7. Key strategic moves and developments
  • 9.8. Insud Pharma S.L
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Marius Pharmaceuticals
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.7. Key strategic moves and developments
  • 9.10. Pfizer Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 02. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR INJECTABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TOPICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 06. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE CYPIONATE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE ENANTHATE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE UNDECANOATE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR HOSPITAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. TESTOSTERONE REPLACEMENT THERAPY MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 19. U.S. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 20. U.S. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 21. U.S. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 22. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 23. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 24. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. UK TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 39. UK TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 40. UK TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 41. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 42. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 43. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 54. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 58. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 59. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 60. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 61. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 62. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 64. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 73. LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 74. LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 75. LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 77. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 78. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. COLOMBIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 80. COLOMBIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 81. COLOMBIA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 83. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 84. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 85. REST OF LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 86. REST OF LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. MIDDLE EAST AND AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 89. MIDDLE EAST AND AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 90. MIDDLE EAST AND AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 91. MIDDLE EAST AND AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 92. GCC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 93. GCC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 94. GCC TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 96. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 97. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. NORTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 99. NORTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 100. NORTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 101. REST OF MEA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 102. REST OF MEA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022-2032 ($MILLION)
  • TABLE 103. REST OF MEA TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. ABBVIE INC.: KEY EXECUTIVES
  • TABLE 105. ABBVIE INC.: COMPANY SNAPSHOT
  • TABLE 106. ABBVIE INC.: PRODUCT SEGMENTS
  • TABLE 107. ABBVIE INC.: SERVICE SEGMENTS
  • TABLE 108. ABBVIE INC.: PRODUCT PORTFOLIO
  • TABLE 109. ABBVIE INC.: KEY STRATERGIES
  • TABLE 110. BESINS HEALTHCARE SA: KEY EXECUTIVES
  • TABLE 111. BESINS HEALTHCARE SA: COMPANY SNAPSHOT
  • TABLE 112. BESINS HEALTHCARE SA: PRODUCT SEGMENTS
  • TABLE 113. BESINS HEALTHCARE SA: SERVICE SEGMENTS
  • TABLE 114. BESINS HEALTHCARE SA: PRODUCT PORTFOLIO
  • TABLE 115. BESINS HEALTHCARE SA: KEY STRATERGIES
  • TABLE 116. ACERUS PHARMACEUTICALS CORPORATION: KEY EXECUTIVES
  • TABLE 117. ACERUS PHARMACEUTICALS CORPORATION: COMPANY SNAPSHOT
  • TABLE 118. ACERUS PHARMACEUTICALS CORPORATION: PRODUCT SEGMENTS
  • TABLE 119. ACERUS PHARMACEUTICALS CORPORATION: SERVICE SEGMENTS
  • TABLE 120. ACERUS PHARMACEUTICALS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 121. ACERUS PHARMACEUTICALS CORPORATION: KEY STRATERGIES
  • TABLE 122. AMNEAL PHARMACEUTICALS INC.: KEY EXECUTIVES
  • TABLE 123. AMNEAL PHARMACEUTICALS INC.: COMPANY SNAPSHOT
  • TABLE 124. AMNEAL PHARMACEUTICALS INC.: PRODUCT SEGMENTS
  • TABLE 125. AMNEAL PHARMACEUTICALS INC.: SERVICE SEGMENTS
  • TABLE 126. AMNEAL PHARMACEUTICALS INC.: PRODUCT PORTFOLIO
  • TABLE 127. AMNEAL PHARMACEUTICALS INC.: KEY STRATERGIES
  • TABLE 128. ACRUX LTD.: KEY EXECUTIVES
  • TABLE 129. ACRUX LTD.: COMPANY SNAPSHOT
  • TABLE 130. ACRUX LTD.: PRODUCT SEGMENTS
  • TABLE 131. ACRUX LTD.: SERVICE SEGMENTS
  • TABLE 132. ACRUX LTD.: PRODUCT PORTFOLIO
  • TABLE 133. ACRUX LTD.: KEY STRATERGIES
  • TABLE 134. ENDO INTERNATIONAL PLC.: KEY EXECUTIVES
  • TABLE 135. ENDO INTERNATIONAL PLC.: COMPANY SNAPSHOT
  • TABLE 136. ENDO INTERNATIONAL PLC.: PRODUCT SEGMENTS
  • TABLE 137. ENDO INTERNATIONAL PLC.: SERVICE SEGMENTS
  • TABLE 138. ENDO INTERNATIONAL PLC.: PRODUCT PORTFOLIO
  • TABLE 139. ENDO INTERNATIONAL PLC.: KEY STRATERGIES
  • TABLE 140. BIOTE MEDICAL LLC: KEY EXECUTIVES
  • TABLE 141. BIOTE MEDICAL LLC: COMPANY SNAPSHOT
  • TABLE 142. BIOTE MEDICAL LLC: PRODUCT SEGMENTS
  • TABLE 143. BIOTE MEDICAL LLC: SERVICE SEGMENTS
  • TABLE 144. BIOTE MEDICAL LLC: PRODUCT PORTFOLIO
  • TABLE 145. BIOTE MEDICAL LLC: KEY STRATERGIES
  • TABLE 146. INSUD PHARMA S.L: KEY EXECUTIVES
  • TABLE 147. INSUD PHARMA S.L: COMPANY SNAPSHOT
  • TABLE 148. INSUD PHARMA S.L: PRODUCT SEGMENTS
  • TABLE 149. INSUD PHARMA S.L: SERVICE SEGMENTS
  • TABLE 150. INSUD PHARMA S.L: PRODUCT PORTFOLIO
  • TABLE 151. INSUD PHARMA S.L: KEY STRATERGIES
  • TABLE 152. MARIUS PHARMACEUTICALS: KEY EXECUTIVES
  • TABLE 153. MARIUS PHARMACEUTICALS: COMPANY SNAPSHOT
  • TABLE 154. MARIUS PHARMACEUTICALS: PRODUCT SEGMENTS
  • TABLE 155. MARIUS PHARMACEUTICALS: SERVICE SEGMENTS
  • TABLE 156. MARIUS PHARMACEUTICALS: PRODUCT PORTFOLIO
  • TABLE 157. MARIUS PHARMACEUTICALS: KEY STRATERGIES
  • TABLE 158. PFIZER INC.: KEY EXECUTIVES
  • TABLE 159. PFIZER INC.: COMPANY SNAPSHOT
  • TABLE 160. PFIZER INC.: PRODUCT SEGMENTS
  • TABLE 161. PFIZER INC.: SERVICE SEGMENTS
  • TABLE 162. PFIZER INC.: PRODUCT PORTFOLIO
  • TABLE 163. PFIZER INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF TESTOSTERONE REPLACEMENT THERAPY MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN TESTOSTERONE REPLACEMENT THERAPY MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN TESTOSTERONE REPLACEMENT THERAPY MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY PRODUCT TYPE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR INJECTABLES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TOPICAL, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY ACTIVE INGREDIENTS, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE CYPIONATE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE ENANTHATE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR TESTOSTERONE UNDECANOATE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR HOSPITAL, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MARKET FOR CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. TESTOSTERONE REPLACEMENT THERAPY MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 25. U.S. TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. UK TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. REST OF EUROPE TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. COLOMBIA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. REST OF LATIN AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. GCC TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. NORTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. REST OF MEA TESTOSTERONE REPLACEMENT THERAPY MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 52. COMPETITIVE DASHBOARD
  • FIGURE 53. COMPETITIVE HEATMAP: TESTOSTERONE REPLACEMENT THERAPY MARKET
  • FIGURE 54. TOP PLAYER POSITIONING, 2022